
Peter Remsen Dottino MD
Gynecologic Oncology
Associate Clinical Professor, Obstetrics, Gynecology and Reproductive Science, Icahn School of Medicine at Mount Sinai
Join to View Full Profile
55 Holly Hill LaneYale New Haven Health Greenwich HospitalWestport, CT 06880
Dr. Dottino is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Icahn School of Medicine at Mount SinaiFellowship, Gynecologic Oncology, 1983 - 1985
- SUNY Downstate Health Sciences UniversityResidency, Obstetrics and Gynecology, 1979 - 1983
- Georgetown University School of MedicineClass of 1979
Certifications & Licensure
- CT State Medical License 2022 - 2025
- NY State Medical License 1981 - 2023
- NJ State Medical License 1996 - 2015
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2004-2014
- Top Doctors: New York Metro Area Castle Connolly, 2002-2014
- New York Magazine: Top Doctors Castle Connolly, 2002-2005, 2012-2014
- Join now to see all
Clinical Trials
- A Study of LY2510924 and Durvalumab in Participants With Solid Tumors Start of enrollment: 2016 Sep 01
Publications & Presentations
PubMed
- 1 citationsMutations in cancer-relevant genes are ubiquitous in histologically normal endometrial tissue.Deep Pandya, Shannon Tomita, Maria Padron Rhenals, Sabina Swierczek, Katherine Reid
Gynecologic Oncology. 2024-06-01 - 1 citationsThe impact of nativity on uterine cancer survival in the public hospital system of Queens, New York.George S Hagopian, Alka Chintamani Bapat, Peter R Dottino, Molly Lieber, M Margaret Kemeny
Gynecologic Oncology. 2024-02-01 - In Vivo and In Vitro Efficacy of Trastuzumab Deruxtecan in Uterine Serous Carcinoma.Levent Mutlu, Diego D Manavella, Stefania Bellone, Blair McNamara, Justin A Harold
Molecular Cancer Therapeutics. 2023-12-01
Press Mentions
- Endometrial Cancer Mutations Are Detectable in Uterine Lavage Fluid Before a Cancer Is DiagnosedOctober 23rd, 2020
- Molecular Techniques Help Identify Ovarian Cancer RecurrenceSeptember 29th, 2017
- Mount Sinai School of Medicine Release: Endometrial Cancer Mutations Are Detectable in Uterine Lavage Fluid Before A Cancer Is DiagnosedDecember 28th, 2016
Professional Memberships
- Fellow
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: